Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Or put the country first This information might be useful
Step 1: Beta-3 Adrenergic Receptor Activation The primary mechanism by which AOD-9604 targets fat cells involves beta-3 adrenergic receptors located on adipocyte (fat cell) membranes
GIP has been shown to decrease food intake while blunting the metabolic adaptive responses that usually occur with calorie restriction resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids
AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone that specifically targets fat metabolism without systemic growth hormone effects
The benefits described are based on third-party studies
Changes in other medications If you start or stop other medications while on semaglutide, inform your prescriber
